Epizyme, Inc. to Report First Quarter Financial Results and Provide Corporate Update on May 13, 2014

[PR Newswire] – CAMBRIDGE, Mass., May 7, 2014 /PRNewswire/ — Epizyme, Inc. (EPZM), a clinical stage biopharmaceutical company creating innovative personalized therapeutics for patients with genetically defined cancers, announced today that it will host more

View todays social media effects on EPZM

View the latest stocks trending across Twitter. Click to view dashboard

See who Epizyme is hiring next, click here to view